Breast Diseases  >>  goserelin acetate 
Welcome,         Profile    Billing    Logout  

3 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
goserelin acetate / Generic mfg.
NCT03137368: A Study to Evaluate Exemestane Tablets Combined With Ovarian Function Suppression/Ablation in Treatment of Premenopausal Breast Cancer Patients With CYP2D6*10 Mutations （STEP）

Enrolling by invitation
3
300
RoW
Exemestane Tablets, ovarian function suppression/ablation, CYP2D6*10 gene test, Tamoxifen
Cancer Institute and Hospital, Chinese Academy of Medical Sciences, Pfizer
CYP2D6 Polymorphism
10/23
10/23
NCT02132390: Adjuvant Toremifene With or Without Goserrelin in Premenopausal Women With Stage I-IIIA, Hormonal Receptor Positive Breast Cancer Accompanied With or Without Chemotherapy Induced Amenorrhoea

Not yet recruiting
3
300
RoW
Goserelin, Zoladex, Toremifene
Peking Union Medical College Hospital
Breast Cancer, Chemotherapy Induced Amenorrhea, Ovarian Function Suppression
05/24
 
SHPD002, NCT02221999: Weekly Paclitaxel and Cisplatin to Treat Hormone Receptor Positive and Triple Negative Breast Cancer Patients

Active, not recruiting
2/3
250
RoW
Paclitaxel, Taxol, Cisplatin, Gonadotropin-releasing hormone agonist, Letrozole
RenJi Hospital
Tubular Breast Cancer, Mucinous Breast Cancer, Invasive Ductal Breast Cancer, Inflammatory Breast Cancer
01/19
01/29

Download Options